Themis Medicare Board to Consider Q2 FY27 Results on 5th Nov'26
Themis Medicare Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Themis Medicare Board to Consider Q2 FY27 Results on 5th Nov'26 Themis Medicare Limited has scheduled its Board of Directors meeting for 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26, alongside the Statutory Auditors' Limited Review Reports. In compliance with SEBI insider trading regulations, the trading window for designated persons remains closed from 1st Oct'26 until 48 hours post the publication of the financial results.
Original exchange filing (PDF)
More announcements from Themis Medicare Ltd
- Please refer to the attachment 路 16 Nov 2026
- Themis Medicare Limited has submitted to the Exchange, the un-audited standalone & consolidated financial results for the quarter and half year ended September 30, 2026. 路 14 Nov 2026
- Kindly refer to the Un-audited standalone and consolidated financial results for the quarter and half year ended 30.09.2026 路 14 Nov 2026
- Kindly refer to the Outcome of the Board Meeting held on 14.11.2026 路 14 Nov 2026
- Themis Medicare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- THEMISMED : 14-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2026, To consider and approve the un-audited standalone & consolidated financial results for the period ended September 30, 2026 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd 路 30 Oct 2026
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October .... 路 29 Oct 2026
